Annual Current Liabilities
$62.23 M
-$6.79 M-9.83%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual total current liabilities is $62.23 million, with the most recent change of -$6.79 million (-9.83%) on June 30, 2024.
- During the last 3 years, AYTU annual current liabilities has fallen by -$47.21 million (-43.14%).
- AYTU annual current liabilities is now -43.14% below its all-time high of $109.44 million, reached on June 30, 2021.
Performance
AYTU Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$61.25 M
-$976.00 K-1.57%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly total current liabilities is $61.25 million, with the most recent change of -$976.00 thousand (-1.57%) on September 30, 2024.
- Over the past year, AYTU quarterly current liabilities has dropped by -$4.21 million (-6.43%).
- AYTU quarterly current liabilities is now -44.03% below its all-time high of $109.44 million, reached on June 30, 2021.
Performance
AYTU Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AYTU Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.8% | -6.4% |
| 3 y3 years | -43.1% | -37.5% |
| 5 y5 years | +1058.3% | -26.8% |
AYTU Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.1% | at low | -39.1% | at low |
| 5 y | 5-year | -43.1% | +1058.3% | -44.0% | +284.0% |
| alltime | all time | -43.1% | >+9999.0% | -44.0% | >+9999.0% |
Aytu BioPharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $61.25 M(-1.6%) |
| Jun 2024 | $62.23 M(-9.8%) | $62.23 M(-25.6%) |
| Mar 2024 | - | $83.69 M(+30.4%) |
| Dec 2023 | - | $64.19 M(-1.9%) |
| Sep 2023 | - | $65.46 M(-5.1%) |
| Jun 2023 | $69.02 M(+7.1%) | $69.02 M(-19.2%) |
| Mar 2023 | - | $85.42 M(+27.2%) |
| Dec 2022 | - | $67.15 M(-8.3%) |
| Sep 2022 | - | $73.20 M(+13.6%) |
| Jun 2022 | $64.44 M(-41.1%) | $64.44 M(-19.8%) |
| Mar 2022 | - | $80.36 M(-20.1%) |
| Dec 2021 | - | $100.57 M(+2.6%) |
| Sep 2021 | - | $98.00 M(-10.5%) |
| Jun 2021 | $109.44 M(+280.5%) | $109.44 M(+30.8%) |
| Mar 2021 | - | $83.68 M(+224.2%) |
| Dec 2020 | - | $25.81 M(+20.0%) |
| Sep 2020 | - | $21.51 M(-25.2%) |
| Jun 2020 | $28.76 M(+435.4%) | $28.76 M(-31.6%) |
| Mar 2020 | - | $42.03 M(+163.5%) |
| Dec 2019 | - | $15.95 M(+161.4%) |
| Sep 2019 | - | $6.10 M(+13.6%) |
| Jun 2019 | $5.37 M(+58.3%) | $5.37 M(+19.3%) |
| Mar 2019 | - | $4.50 M(-3.3%) |
| Dec 2018 | - | $4.66 M(+29.8%) |
| Sep 2018 | - | $3.59 M(+5.7%) |
| Jun 2018 | $3.39 M(-6.0%) | $3.39 M(-21.8%) |
| Mar 2018 | - | $4.34 M(-9.6%) |
| Dec 2017 | - | $4.80 M(+36.8%) |
| Sep 2017 | - | $3.51 M(-2.8%) |
| Jun 2017 | $3.61 M(-64.3%) | $3.61 M(+7.6%) |
| Mar 2017 | - | $3.35 M(-51.9%) |
| Dec 2016 | - | $6.97 M(-20.2%) |
| Sep 2016 | - | $8.73 M(-13.6%) |
| Jun 2016 | $10.10 M | $10.10 M(+215.2%) |
| Mar 2016 | - | $3.21 M(+14.3%) |
| Dec 2015 | - | $2.80 M(+57.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $1.78 M(+20.3%) |
| Jun 2015 | $1.48 M(+2825.9%) | $1.48 M(-83.9%) |
| Mar 2015 | - | $9.20 M(>+9900.0%) |
| Feb 2015 | - | $60.90 K(+10.3%) |
| Nov 2014 | - | $55.20 K(+9.3%) |
| Aug 2014 | $50.50 K(-99.2%) | $50.50 K(+2.0%) |
| Jun 2014 | $6.09 M(+4955.9%) | - |
| May 2014 | - | $49.50 K(-67.7%) |
| Feb 2014 | - | $153.40 K(+15.0%) |
| Nov 2013 | - | $133.40 K(+10.7%) |
| Aug 2013 | $120.50 K(+46.2%) | $120.50 K(+4.3%) |
| May 2013 | - | $115.50 K(+7.0%) |
| Feb 2013 | - | $107.90 K(+14.7%) |
| Nov 2012 | - | $94.10 K(+14.2%) |
| Aug 2012 | $82.40 K(+41.1%) | $82.40 K(+19.4%) |
| May 2012 | - | $69.00 K(+5.0%) |
| Feb 2012 | - | $65.70 K(-1.1%) |
| Nov 2011 | - | $66.40 K(+13.7%) |
| Aug 2011 | $58.40 K(-29.4%) | $58.40 K(-12.0%) |
| May 2011 | - | $66.40 K(+26.2%) |
| Feb 2011 | - | $52.60 K(-43.1%) |
| Nov 2010 | - | $92.40 K(+11.7%) |
| Aug 2010 | $82.70 K(+49.3%) | $82.70 K(-1.8%) |
| May 2010 | - | $84.20 K(+24.7%) |
| Feb 2010 | - | $67.50 K(+10.3%) |
| Nov 2009 | - | $61.20 K(+10.5%) |
| Aug 2009 | $55.40 K(+15.2%) | $55.40 K(0.0%) |
| May 2009 | - | $55.40 K(+5.5%) |
| Feb 2009 | - | $52.50 K(+4.8%) |
| Nov 2008 | - | $50.10 K(+4.2%) |
| Aug 2008 | $48.10 K(+17.6%) | $48.10 K(+8.6%) |
| May 2008 | - | $44.30 K(+10.2%) |
| Feb 2008 | - | $40.20 K(-6.7%) |
| Nov 2007 | - | $43.10 K(+5.4%) |
| Aug 2007 | $40.90 K | $40.90 K(+6.0%) |
| May 2007 | - | $38.60 K |
FAQ
- What is Aytu BioPharma annual total current liabilities?
- What is the all time high annual current liabilities for Aytu BioPharma?
- What is Aytu BioPharma annual current liabilities year-on-year change?
- What is Aytu BioPharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aytu BioPharma?
- What is Aytu BioPharma quarterly current liabilities year-on-year change?
What is Aytu BioPharma annual total current liabilities?
The current annual current liabilities of AYTU is $62.23 M
What is the all time high annual current liabilities for Aytu BioPharma?
Aytu BioPharma all-time high annual total current liabilities is $109.44 M
What is Aytu BioPharma annual current liabilities year-on-year change?
Over the past year, AYTU annual total current liabilities has changed by -$6.79 M (-9.83%)
What is Aytu BioPharma quarterly total current liabilities?
The current quarterly current liabilities of AYTU is $61.25 M
What is the all time high quarterly current liabilities for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total current liabilities is $109.44 M
What is Aytu BioPharma quarterly current liabilities year-on-year change?
Over the past year, AYTU quarterly total current liabilities has changed by -$4.21 M (-6.43%)